Cancer therapeutics biotech BeyondSpring scored $54.3 million in a combination IPO and private placement. The total falls well short of its initial $100…

Nonprofit Parkinson’s UK has teamed up with the University of Sheffield to create a virtual biotech.

Texas biotech ImmunoMet raises $5 million in a second-round fundraising that paves the way for a first clinical trial of its lead cancer drug.

Deborah Dunsire has achieved the rare feat, on International Women’s Day no less, of becoming CEO of an early-stage biotech after being officially named as…

Arix Bioscience has teamed up with Takeda Ventures to create and grow biotechs.

In a typically fiery speech, President Donald Trump in his first joint address to Congress last night tore into the FDA’s “slow and burdensome approval process…

Pharma Two B has raised $30 million to complete a phase 3 trial of its Parkinson’s asset P2B001 and added ex-Pfizer CEO Jeff Kindler to its board.

Exonics Therapeutics has won $5 million in seed funding toward its goal of using cutting-edge new gene editing technology to help correct the majority of DMD…

Venture Capital